Eliminate stubborn bacterial infections with the targeted power of Hovid Cloxacap 250mg. Containing Cloxacillin Sodium, this specialized narrow-spectrum antibiotic is specifically designed to combat penicillinase-producing staphylococci—bacteria that have developed resistance to standard penicillins. Cloxacap is a frontline defense for a wide range of conditions, including skin and soft tissue infections (such as boils or cellulitis), respiratory tract infections, and infections following surgical procedures. By inhibiting the cell wall synthesis of pathogenic bacteria, it ensures rapid containment of the infection and prevents systemic spread (septicemia). Whether used for post-operative protection or treating acute localized infections, Hovid Cloxacap provides the pharmaceutical reliability needed for a full and uncomplicated recovery.

• Specialized Resistance: Specifically targets bacteria that produce enzymes to destroy ordinary penicillin.

• Broad Clinical Scope: Effective for skin, bone, joint, and respiratory tract infections.

• Post-Surgical Shield: Ideal for preventing infections in wounds and soft tissues after surgery.

• Rapid Bioavailability: Reaches therapeutic levels quickly to halt bacterial proliferation.

• Quality Assured: MAL19076014AZ registered, adhering to Hovid’s high manufacturing standards.

Usage Instructions:

• Adults: 250mg to 500mg (1-2 capsules) every 6 hours, or as directed by a healthcare professional.

• Administration: Swallow capsules whole. Can be taken with food or milk to minimize gastric discomfort.

• Course Completion: Must complete the full course to prevent bacterial resistance, even if feeling better.